<DOC>
	<DOCNO>NCT00195585</DOCNO>
	<brief_summary>The purpose study verify superiority 1-LV/5FU therapy UFT Therapy relapse-free survival time patient Dukes C Cure A colon cancer . Secondary endpoint include disease-free survival time , survival time , safety .</brief_summary>
	<brief_title>Study Evaluating Isovorin Colon Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>Dukes C , Cure A colon cancer diagnose histologically cytologically Normal organ function bone marrow , heart , liver kidney Age 2075 Other inclusion applies Serious bone marrow suppression , infection , heart disease complication Familial adenomatous polyposis hereditary nonpolyposis Pregnant breastfeeding woman Other exclusion applies</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Colon Cancer</keyword>
</DOC>